Find uplifting stories about heroes, innovations, and solutions
3537 results for "cancer vaccines"
Since the HPV vaccine became available in 2006, cervical cancer rates have dropped 27% among young American women, with some states seeing reductions over 50%. Every 10% increase in vaccination rates translates to nearly 12% fewer cancer cases.
A personalized mRNA vaccine helped 11 women with aggressive breast cancer stay cancer-free for up to six years. The groundbreaking treatment trained their immune systems to recognize and fight cancer cells using their own tumor's genetic code.
A groundbreaking cancer vaccine has nearly eliminated cervical cancer in young women, with doctors reporting they rarely see the disease in patients under 25 anymore. The success story reveals how vaccines can prevent cancer and save lives.
A groundbreaking breast cancer vaccine has received patent approval in South Korea, marking a major step toward preventing the world's most common cancer in women. The vaccine showed promising safety results and immune responses in 74% of trial participants.
A groundbreaking 18-year study from Sweden shows the HPV vaccine provides lasting protection against cervical cancer, with no signs of weakening over time. Nearly a million women participated in research that could help eliminate cervical cancer as a public health threat.
A woman's dog detected her breast cancer by pressing his nose to a lump on her chest. Now she's part of a groundbreaking vaccine trial that could prevent aggressive breast cancer from returning.
Cervical cancer is one of the most preventable cancers, yet it claims thousands of lives each year. A safe, proven vaccine could change that story completely.
After political backlash threatened to derail cancer research, mRNA vaccines are delivering real hope to patients with deadly diseases like pancreatic cancer. New funding and positive trial results suggest the technology could save thousands of lives.
A personalized DNA vaccine for glioblastoma, one of the deadliest brain cancers, helped patients live twice as long as usual in a groundbreaking trial. One patient remains cancer-free nearly five years later.
A personalized DNA vaccine for glioblastoma, one of the deadliest brain cancers, doubled survival rates in early trials and kept one patient cancer-free for nearly five years. The vaccine trains each patient's immune system to recognize up to 40 unique cancer proteins, making it harder for tumors to hide.
Every woman from a small 2000s breast cancer vaccine trial is alive today, decades past typical survival odds. Scientists now know why their immune systems stayed cancer-ready for 20 years.
After 25 years at NBC News, Kristen Dahlgren left her dream job to solve a problem she discovered during her own breast cancer treatment: life-saving vaccine research wasn't reaching patients fast enough. Now she's partnering with one of America's top cancer research institutes to change that.
A personalized mRNA vaccine helped eight pancreatic cancer patients generate powerful immune responses, and seven of them are still alive six years later. The breakthrough offers new hope for one of the deadliest cancers, where fewer than 13% of patients survive five years.
Scientists have designed a cancer vaccine that successfully fought HPV-related throat tumors in mice, offering hope for people battling these aggressive cancers. The breakthrough lies in how the vaccine's components are arranged, making it more effective at training the immune system to recognize and destroy cancer cells.
A groundbreaking study of 1.7 million Americans reveals that HPV vaccination slashes head and neck cancer rates by more than half in men. As smoking declines but these cancers rise, scientists have found the solution hiding in plain sight.
A personalized mRNA cancer vaccine combined with immunotherapy reduced the risk of deadly skin cancer returning by nearly 50% over five years. The breakthrough treatment is now entering final-stage trials while researchers test similar vaccines for lung, bladder, and kidney cancers.
South Africa is expanding its lifesaving HPV vaccination campaign to reach every girl in the country, protecting them from cervical cancer that kills over 3,000 women annually. Since 2014, the program has already vaccinated 3.6 million girls with more than 7.2 million doses administered.
A groundbreaking study shows personalized mRNA vaccines combined with immunotherapy kept nearly 70% of melanoma patients cancer-free after five years, compared to just 49% with immunotherapy alone. The same technology that powered COVID-19 vaccines is now transforming how we fight cancer.
A personalized mRNA vaccine is helping pancreatic cancer patients survive six years and counting, with nearly 90% of responders still alive. For a disease with just 13% five-year survival, this breakthrough offers real hope.
Kenya just made one of the world's most preventable cancers far easier to stop. A single HPV shot now protects girls for life, removing the biggest barriers to vaccination.
Showing 20 of 3537